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Abstract 
Tight junction proteins are important for intestinal homeostasis. They prevent paracellular transport of 
large molecules and maintain cell polarity. Impaired tight junction function leads to a more permeable 
intestinal epithelial barrier and therefore potentially increases disease risk. Limited information is 
available concerning the effects of food components on the intestinal barrier, particularly paracellular 
permeability and tight junction proteins. In vitro studies with intestinal epithelial cells and in vivo studies 
using animal models have demonstrated that dietary n-3 and n-6 polyunsaturated fatty acids (PUFAs), 
particularly n-3, can reduce intestinal inflammation and permeability. PUFAs can induce transcriptional 
regulators which may act in combination with their target molecules in defense against oxidative stress, 
thereby maintaining the intestinal barrier function. More studies that take into account the type and/or 
amount of individual fatty acids are needed in order to elucidate the molecular mechanisms of PUFAs on 
intestinal epithelial barrier function. 
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ABSTRACT: Tight junction proteins are important for intestinal homeostasis. They prevent paracellular transport of large molecules 
and maintain cell polarity. Impaired tight junction function leads to a more permeable intestinal epithelial barrier and therefore 
potentially increases disease risk. Limited information is available concerning the effects of food components on the intestinal 
barrier, particularly paracellular permeability and tight junction proteins. In vitro studies with intestinal epithelial cells and in vivo 
studies using animal models have demonstrated that dietary n-3 and n-6 polyunsaturated fatty acids (PUFAs), particularly n-3, 
can reduce intestinal inflammation and permeability. PUFAs can induce transcriptional regulators which may act in combination 
with their target molecules in defense against oxidative stress, thereby maintaining the intestinal barrier function. More studies 
that take into account the type and/or amount of individual fatty acids are needed in order to elucidate the molecular 
mechanisms of PUFAs on intestinal epithelial barrier function.
Nicole C. Roy
INTRODUCTION
The luminal environment of the gastrointestinal tract contains 
nutrients and beneficial microbes but is also laden with 
potentially hostile microbes and toxins. Therefore, the intestinal 
tract has two primary functions; to digest and absorb nutrients, 
and to act as a protective barrier (microbiological, chemical, 
epithelial, immunological and neural) between the body and 
the intestinal lumen.
The epithelial cell layer of the gastrointestinal barrier is an 
important gatekeeper that determines what will enter the 
bloodstream. In addition to other forms of intestinal transport 
(e.g. transcellular carrier-mediated, passive diffusion, facilitated) 
the paracellular transport pathway is important for the transport 
of small molecules and large hydrophilic compounds and 
preventing movement of large molecules.
Tight junctions are a mesh-like network of lipoproteins and 
filamentous strands traversing the lateral plasma membrane that 
interact with the adjacent cell’s 
proteins (1, 2, Figure 1). These form 
a dynamic multi-protein complex 
that is connected to the actin 
cytoskeleton (3-8) and by their apical 
location, they determine paracellular 
permeability (9). They also restrict 
transport of membrane lipids and 
proteins from the basolateral to the 
apical compartment and vice versa. 
This ensures the maintenance of cell 
polarity and the specialized properties 
of the different compartments such 
as differential transporter expression 
(3, 10). Moreover, tight junctions 
play a crucial role in intestinal cell 
differentiation, proliferation and 
polarization, and are part of many 
intracellular signaling cascades (11). 
They also act as a docking site for 
endosome vesicle/cytoskeleton 
polarized transport pathways (12, 13).
Tight junction function is regulated 
by a multitude of developmental (14, 15), physiological (16), and 
pathological stimuli (17). during normal food absorption, the tight 
junctions loosen to allow nutrient absorption, a process which 
involves a number of factors including luminal glucose levels and 
the sodium/glucose-co-transporter-mediated myosin light chain 
phosphorylation (18-20). Cytokines (5, 21, 22) or hormones (23) 
also influence tight junction-mediated paracellular permeability. 
Alteration of the barrier function of the intestine is accompanied 
by an inflammatory response. When the intestinal barrier is 
disturbed, antigen uptake is increased and may intensify or even 
initiate inflammation. Water from the bloodstream is also able to 
reach the intestinal lumen to a much greater extent, resulting in 
leak flux diarrhea (24). Impaired tight junction function leads to 
a more permeable intestinal epithelial barrier, which is thought 
to be a contributing factor in the occurrence of a number of 
conditions, including autoimmune and/or allergic diseases such 
as inflammatory bowel disease (IBD, 25-30), multiple sclerosis (31), 
type I diabetes (32), asthma (33) and atopic eczema (34).
Figure 1. Schematic representation of enterocytes showing the main types of cell junctions (e.g. 
tight junctions). Tight junctions are a mesh-like network of lipoproteins and filamentous strands 
traversing the lateral plasma membrane that interact with the cell architecture. (Adapted from 
HF Lodish, 2000, Molecular Cell Biology, 4th edition, WH Freemann, New York).
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of inflammation and prevented redistribution of tight junction 
proteins in a rat model of experimental colitis (50). 
EFFECT ON IMMUNE CELLS
The effects of PUFAs on immune cells and other tissues are partly 
due to changes in the lipid composition of the cell membrane and 
alterations to the binding of ligands or signaling molecules. Fish 
oil contains n-3 PUFAs, such as EPA and dHA, which have been 
shown to improve the immune response in experimental models 
of IBD (51) and to have beneficial effects on inflammatory bowel 
disorders through modulation of immune responses (52). Some 
membrane-bound enzymes and receptors are sensitive to the 
fatty acids that surround them. Genome-wide analysis of dietary 
EPA compared to oleic acid (oA, fatty acid control diet) in the 
colon of the interleukin-10 gene-deficient (Il10–/–) mouse model 
of IBD identified typical fatty acid responsive genes involved in 
fatty acid binding, transport and oxidation. This included known 
peroxisome proliferator-activated receptor (PPAR) target genes 
and other genes that respond to fatty acids via a mechanism 
that is likely to be PPAR-independent (53). dietary EPA increased 
the expression levels of the Ppara gene and some of the PPARα-
dependently regulated genes involved in fatty acid catabolism 
in the colon of Il10–/– mice (53). The Ppara gene most likely 
suppresses inflammatory responses via inhibition of NFκB. 
While n-3 and n-6 PUFAs are both natural ligands for PPARα, n-3 
PUFAs are considered as more potent activators of PPARα than 
n-6 PUFAs (54). The type of individual fatty acid has to be taken 
into account in order to elucidate the molecular mechanisms 
of PUFAs on the intestinal epithelial barrier function. It has been 
reported that intestinal absorption of the n-9 monounsaturated 
fatty acid oA, but not its ethyl ester, induces mucosal injury 
and increases intestinal permeability in the developing piglet 
intestine (55). This oA-induced mucosal injury is abolished when 
the carboxylic group of the fatty acid is esterified with a nonpolar 
ethyl group. These authors also suggest that fatty acids supplied 
in an ethyl ester form could provide fatty acids to the intestine 
without causing mucosal damage. Although fatty acid ethyl 
esters are absorbed and metabolized similarly to free fatty acids, 
triglycerides containing fatty acid ethyl esters represent a more 
natural way of delivery.
PUFAs, OXIDATIVE STRESS AND INTESTINAL BARRIER FUNCTION
There is evidence that IBd is accompanied by increased 
levels of reactive oxygen species and decreased levels of 
antioxidants (56). oxidative stress results from diminished cellular 
antioxidant protection mechanisms and can lead to increased 
cell damage and apoptosis (57). oxidative stress has been 
suggested as a potential trigger for IBd (56). Increased oxidative 
stress during intestinal inflammation can also lead to increased 
endogenous oxidation of dietary PUFAs (58), with n-3 PUFAs 
being more prone to peroxidation than n-6 PUFAs. Sethi et al. 
(58) showed that oxidized, but not native unoxidized, EPA inhibits 
lipopolysaccharide-induced endothelial-leukocyte interactions 
through PPARα activation during inflammation in vitro and in vivo. 
They also suggested that activation of PPARα by oxidized EPA is 
responsible for the anti-inflammatory properties of fish oil. 
Many genes implicated in oxidative stress, such as cytochrome 
P450 isoenzymes (CYP450s), glutathione S-transferases (GSTs) 
and solute carrier (SLC) transporters, are involved in intestinal 
barrier function (59). The effect of dietary lipids (in the form of 
synthetic triglycerides consisting of one single unsaturated fatty 
acid such as EPA, dHA or oA) on small intestinal barrier gene 
expression in Ppara–/– and wildtype mice has been investigated 
(59). This study found that many intestinal barrier genes were 
regulated by PPARα, which seems to be an important receptor 
There is increasing interest in reducing disease risk based on 
dietary supplementation with food components which have 
potential immunomodulatory and barrier protective effects. 
Limited information is available concerning the effect of 
food components on intestinal barrier function, paracellular 
permeability and tight junction proteins. Immunomodulatory 
and barrier-protective effects have previously been described 
for glutamine, polyunsaturated fatty acids (PUFAs), zinc, and 
polyphenols. This short review focuses on the effects of dietary 
PUFAs on intestinal barrier function in the context of intestinal 
inflammation.
IMPACT OF PUFAs ON INTESTINAL HOMEOSTASIS
Several immunomodulatory effects on PUFAs in intestinal 
inflammation have recently been investigated, e.g. modulation 
of pro- and anti-inflammatory eicosanoids, membrane fluidity, 
signal transduction, antigen presentation, gene expression and 
gastrointestinal flora (35). Eicosanoids act directly on immune 
cells and are modulated themselves by PUFAs (35). PUFAs play an 
important role in membrane structure where their incorporation 
into cellular membrane phospholipids increases membrane 
fluidity, affects the conformation of membrane protein 
complexes and serves as a precursor to eicosanoid synthesis 
(36). Moreover, PUFAs can stimulate cell differentiation, support 
intestinal maturation, reduce transcellular permeability and may 
improve tight junction formation (37, 38) and have been shown 
to stabilize the intestinal barrier by increased expression of tight 
junction proteins (39).
INTESTINAL PERMEABILITY
There are few reports of in vitro studies into the effects of n-3 and 
n-6 PUFAs on intestinal permeability. It has been reported that n-3 
eicosapentaenoic acid (EPA), n-6 γ-linolenic acid (GLA), and n-3 
docosahexaenoic acid (dHA) affect tight junction permeability 
in human colonic adenocarcinoma (Caco-2) monolayer cells. 
This occurs both specifically and concentration dependently, by 
enhancing permeability and lowering transepithelial electrical 
resistance (TER) (40, 41). In contrast, EPA and dHA support 
epithelial barrier integrity in T84 cell monolayers by improving 
TER and reducing IL4–mediated permeability (42). A role for n-6 
arachadonic acid (AA) in supporting barrier integrity has also 
been suggested (42). other studies using Caco-2 cells showed 
that EPA and n-6 linolenic acid (LA) do not affect TER (43), while 
prolonged LA incubation enhances TER (44). Improved barrier 
function observed with GLA and EPA appears to be linked 
to increased expression of the tight junction protein occludin 
in endothelial cells (38, 45). In another in vitro study, dHA and 
EPA prevented the disruption of epithelial barrier function and 
redistribution of key tight junction proteins (occludin and Zo1) 
induced by pro-inflammatory cytokines (46). Understanding the 
mechanisms by which n-3 PUFAs prevent disruption of intestinal 
barrier will contribute to the development of therapeutic 
strategies to intestinal barrier defects.
There is also in vivo evidence of PUFAs affecting intestinal 
barrier function. A diet enriched in n-6 PUFA (safflower oil) 
reduced the permeability and mucosal neutrophil infiltration 
in rats with neutrophil-mediated ileal inflammation; this effect 
was not observed in rats fed an n-3 PUFA-enriched (fish oil) 
diet (47). AA and dHA have been shown to decrease the 
development of necrotizing enterocolitis in neonatal rats, most 
likely by improving barrier function (48). on the other hand, a 
study showed that dietary n-3 PUFAs reduce clinical colitis and 
colonic immunopathology possibly by enhancing epithelial 
barrier function and mucosal wound healing processes in a colitis 
mouse model (49). n-3 PUFAs also improved the histological signs 
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mediating the impact of dietary lipids 
on the intestinal barrier. Similarly, the 
expression levels of several genes 
coding for CYP450s and GSTs were 
increased in the colon of EPA- and 
AA-fed Il10–/– mice compared to 
oA-fed Il10–/– mice (53, 60, Figure 
2). CYP450s are phase I metabolic 
enzymes that induce oxidative 
stress by oxidative, peroxidative 
and reductive metabolism of 
endogenous substrates such as 
fatty acids (61), whereas GSTs 
are phase II metabolic enzyme 
genes involved in oxidative stress 
defense (62). The expression levels 
of other phase II enzyme genes 
such as sulfotransferases (SULTs) 
and UdP-glucuronosyltransferases 
(UGTs) were also increased in the 
colon of Il10–/– mice after feeding 
EPA- and AA-enriched diets 
(Figure 2). These represent target 
genes of the hepatocyte nuclear 
factor 4α (HNF4α) which, itself, 
was not modulated under 
inflammatory conditions (Figure 3). 
HNF4α plays a crucial role in the 
promotion of intestinal epithelial 
barrier function (63). It increases the 
abundance of cell junction proteins 
Figure 3. Biological interaction network of genes associated with the top-regulated pathways in 
the colon of interleukin-10 gene-deficient (Il10–/–) mice compared to C57 (wild-type) mice fed 
an oleic acid (oA) diet, generated using Ingenuity Pathway Analysis software. The 
“Neighborhood Explorer” feature was used to investigate central nodes (in bold) in order to 
find molecules that directly interact with other molecules in the network. Most down-regulated 
genes associated with the regulation of intestinal barrier function linked to peroxisome 
proliferator-activated receptor alpha (Ppara) and hepatic nuclear factor 4 alpha (Hnfa) genes 
which itself remained unchanged (not in bold). Genes or gene products are represented as 
nodes, and the biological relationship between two nodes is represented as an edge. All edges 
are supported by at least one reference from the literature. Color coding: red, up-regulated 
gene; green, down-regulated gene. The intensity of the colours specifies the degree of up- or 
down-regulation. Greater intensity represents a higher expression level. *Genes that are 
detected two or more times on the microarray.
Figure 2. Heat map (supervised hierarchical clustering) showing the expression levels of some of the genes associated with the regulation of 
the intestinal barrier function that are differentially expressed in the colon of: (a) oleic acid (oA)-fed interleukin-10 gene-deficient (Il10–/–) 
compared to C57 (wild-type) mice on the same diet; (b) arachidonic acid (AA)- compared to oA-fed Il10–/–  mice, and (c) 
eicosapentaenoic acid (EPA)- compared to oA-fed Il10–/– mice. Up-regulated genes are represented in red tones and down-regulated 
genes in green tones. 
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such as occludin and claudins (CLdNs), and modulates subcellular localization 
of proteins related to epithelial polarization (64). Some SLCs are also involved in 
oxidative stress defense and, together with CYP450s and GSTs, are PPARα- or 
HNF4α-dependently regulated. The biological interaction network generated 
from published microarray data (53, 60) shows decreased expression levels 
of these PPARα- and HNF4α-dependently regulated genes in the inflamed 
colon of Il10–/– mice fed oA diet compared to C57 (wild-type) mice (Figure 3), 
whereas dietary EPA and AA, which reduced colon inflammation, had the 
opposite effect. Expression levels of genes coding for junction molecules (Cldn8, 
Gja7 and Tjp1), the latter of which are cytoskeleton-associated molecules, 
remained unchanged in EPA- and AA-fed Il10–/– mice compared to oA-fed 
Il10–/– mice, but Cldn8 and Gja7 were decreased in abundance in oA-fed Il10–/– 
compared to C57 mice (Figure 2).
Literature reports and the biological network presented here suggest that PUFAs 
can induce transcriptional regulators which might act in combination with their 
target molecules in defense against oxidative stress to maintain intestinal barrier 
function. Together these results provide insights of potential important roles for n-3 
and n-6 PUFAs in maintaining/improving intestinal barrier function and thereby 
attenuating intestinal inflammation. Further studies that utilize post-genome 
technologies (including epigenomics, proteomics and metabolomics), and that 
take into account the type and/or amount of individual fatty acids, are required 
to further elucidate the molecular mechanisms of PUFAs. These may be of 
particular importance in developing therapeutic strategies that address intestinal 
tight junction barrier defects in IBd.
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